Standout Papers
Citation Impact
9 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Works of Yan‐Jun Xiang being referenced
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Transcatheter Arterial Chemoembolization Plus Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma: a Single-Arm, Phase II Trial
2022
Author Peers
| Author | Hepatology | Surgery | PFM | Oncology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Yan‐Jun Xiang | 204 | 48 | 65 | 73 | 73 | 28 | 259 | |
| Jiachun Ge | 4 | 1 | 1 | 38 | 514 | |||
| Анна А. Штро | 4 | 7 | 10 | 21 | 187 | 62 | 934 | |
| Antje Winkler | 4 | 129 | ||||||
| Geri Kreitzer | 22 | 140 | 44 | 129 | 110 | 35 | 2.4k | |
| R. Rabe | 1 | 8 | 341 |
All Works
Login with ORCID to disown or claim papers
Loading papers...